ProfileGDS4459 / ENSG00000089597
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 60% 31% 82% 58% 71% 61% 78% 81% 74% 82% 55% 78% 77% 28% 75% 44% 48% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.7960
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.831
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.482
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.7758
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3971
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.8361
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.0578
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.2881
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.774
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.3482
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.4955
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.0978
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.8877
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.7128
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.8475
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.2244
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.348